9/30
11:26 am
acxp
Acurx Pharmaceuticals (NASDAQ:ACXP) had its "buy" rating reaffirmed by analysts at HC Wainwright. They now have a $31.00 price target on the stock.
Low
Report
Acurx Pharmaceuticals (NASDAQ:ACXP) had its "buy" rating reaffirmed by analysts at HC Wainwright. They now have a $31.00 price target on the stock.